Table 3: Effect of intraperitoneal administration of deoxyelephantopin on the life span of DLA-tumour-bearing mice.

TreatmentsNumber of mice survived after tumour inoculation (days)Mean survival time (days)Life span (%)Increase in life span (%)
152535

Group I DLA (Control)10/105/100/10 2 2 . 5 6 ± 2 . 5 7 100
Group II DLA + Deoxy-elephantopin (25 mg/kg, i.p)10/106/103/10 3 0 . 9 0 ± 3 . 3 6 136.9636.96
Group III DLA + Deoxy-elephantopin (50 mg/kg, i.p)10/108/105/10 3 7 . 8 2 ± 3 . 7 0 167.6467.64
Group IV DLA + Deoxy-elephantopin (100 mg/kg, i.p)10/108/106/10 3 8 . 9 2 ± 3 . 5 172.5172.51
Group V DLA + Vincristine (1 mg/kg, i.p)10/1010/106/10 4 3 . 5 4 ± 3 . 9 192.9992.99

Values are mean ± SD of three experiments, 𝑛 = 1 0 , *** 𝑃 < 0 . 0 0 1 compared to control (the time period required for the death of all the animals in the control group was 22).